NSEDCP
NJ State Employees Deferred Compensation Plan’s Xenon Pharmaceuticals XENE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $783K | Hold |
25,000
| – | – | 0.09% | 205 |
|
2025
Q1 | $839K | Hold |
25,000
| – | – | 0.11% | 186 |
|
2024
Q4 | $980K | Hold |
25,000
| – | – | 0.12% | 177 |
|
2024
Q3 | $984K | Hold |
25,000
| – | – | 0.12% | 180 |
|
2024
Q2 | $975K | Hold |
25,000
| – | – | 0.12% | 172 |
|
2024
Q1 | $1.08M | Hold |
25,000
| – | – | 0.14% | 165 |
|
2023
Q4 | $1.15M | Hold |
25,000
| – | – | 0.16% | 144 |
|
2023
Q3 | $854K | Hold |
25,000
| – | – | 0.13% | 173 |
|
2023
Q2 | $963K | Hold |
25,000
| – | – | 0.14% | 167 |
|
2023
Q1 | $895K | Hold |
25,000
| – | – | 0.14% | 176 |
|
2022
Q4 | $986K | Hold |
25,000
| – | – | 0.16% | 151 |
|
2022
Q3 | $903K | Hold |
25,000
| – | – | 0.15% | 154 |
|
2022
Q2 | $761K | Hold |
25,000
| – | – | 0.12% | 177 |
|
2022
Q1 | $764K | Hold |
25,000
| – | – | 0.1% | 203 |
|
2021
Q4 | $781K | Hold |
25,000
| – | – | 0.1% | 211 |
|
2021
Q3 | $382K | Hold |
25,000
| – | – | 0.05% | 347 |
|
2021
Q2 | $466K | Hold |
25,000
| – | – | 0.06% | 315 |
|
2021
Q1 | $448K | Hold |
25,000
| – | – | 0.06% | 323 |
|
2020
Q4 | $385K | Hold |
25,000
| – | – | 0.06% | 329 |
|
2020
Q3 | $277K | Hold |
25,000
| – | – | 0.05% | 343 |
|
2020
Q2 | $314K | Hold |
25,000
| – | – | 0.06% | 312 |
|
2020
Q1 | $284K | Hold |
25,000
| – | – | 0.06% | 297 |
|
2019
Q4 | $328K | Hold |
25,000
| – | – | 0.06% | 381 |
|
2019
Q3 | $225K | Hold |
25,000
| – | – | 0.04% | 457 |
|
2019
Q2 | $247K | Hold |
25,000
| – | – | 0.04% | 480 |
|
2019
Q1 | $254K | Hold |
25,000
| – | – | 0.05% | 471 |
|
2018
Q4 | $158K | Hold |
25,000
| – | – | 0.03% | 482 |
|
2018
Q3 | $330K | Sell |
25,000
-25,000
| -50% | -$330K | 0.06% | 417 |
|
2018
Q2 | $460K | Buy |
50,000
+30,000
| +150% | +$276K | 0.08% | 330 |
|
2018
Q1 | $98K | Hold |
20,000
| – | – | 0.02% | 465 |
|
2017
Q4 | $57K | Hold |
20,000
| – | – | 0.01% | 459 |
|
2017
Q3 | $59K | Hold |
20,000
| – | – | 0.01% | 454 |
|
2017
Q2 | $63K | Hold |
20,000
| – | – | 0.01% | 407 |
|
2017
Q1 | $80K | Hold |
20,000
| – | – | 0.02% | 382 |
|
2016
Q4 | $154K | Hold |
20,000
| – | – | 0.03% | 353 |
|
2016
Q3 | $162K | Hold |
20,000
| – | – | 0.03% | 346 |
|
2016
Q2 | $118K | Hold |
20,000
| – | – | 0.03% | 359 |
|
2016
Q1 | $143K | Hold |
20,000
| – | – | 0.03% | 359 |
|
2015
Q4 | $161K | Hold |
20,000
| – | – | 0.03% | 361 |
|
2015
Q3 | $165K | Hold |
20,000
| – | – | 0.04% | 360 |
|
2015
Q2 | $231K | Buy |
+20,000
| New | +$231K | 0.04% | 346 |
|